{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:46:42Z","timestamp":1792504002546,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1241450"],"award-info":[{"award-number":["1241450"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cld.2026.01.014","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:32:32Z","timestamp":1772569952000},"page":"529-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-417X","authenticated-orcid":false,"given":"Claudia P.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-7348","authenticated-orcid":false,"given":"Mario Guimar\u00e3es","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-4930","authenticated-orcid":false,"given":"Luis Antonio","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-2472","authenticated-orcid":false,"given":"Adrian","family":"Gadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-4191","authenticated-orcid":false,"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2026.01.014_bib1","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cld.2026.01.014_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70127","article-title":"The global burden of MASLD in the past three decades","volume":"45","author":"Paik","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.014_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2026.01.014_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cld.2026.01.014_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cld.2023.01.015","article-title":"Nonalcoholic fatty liver disease in Latin America and Australia","volume":"27","author":"Castellanos-Fernandez","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2026.01.014_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101175","article-title":"The burden of liver disease in Latin America","volume":"29","author":"Diaz","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cld.759","article-title":"Nonalcoholic fatty liver disease risk factors in Latin American populations: current scenario and perspectives","volume":"13","author":"Pinto Marques Souza de Oliveira","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2026.01.014_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cgh.2024.06.038","article-title":"Disparities for Hispanic adults with metabolic dysfunction-associated steatotic liver disease in the United States: a systematic review and meta-analysis","volume":"23","author":"Tesfai","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep.32743","article-title":"Health disparities in chronic liver disease","volume":"77","author":"Kardashian","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2026.01.014_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jamainternmed.2025.4769","article-title":"Targeting MASLD and MASH in the US Hispanic\/Latino population: a review","volume":"185","author":"Cumpian","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.cld.2026.01.014_bib12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/HEP.0000000000001211","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease and fibrosis defined by liver elastography in the United States using National Health and Nutrition Examination Survey 2017-March 2020 and August 2021-August 2023 data","volume":"82","author":"Unalp-Arida","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.014_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s43856-024-00649-x","article-title":"Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria","volume":"4","author":"Diaz","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.cld.2026.01.014_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100359","article-title":"NAFLD: challenges and opportunities to address the public health problem in Latin America","volume":"24","author":"Arab","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100706","article-title":"Non-alcoholic fatty liver disease prevalence in Latin America: a systematic review and meta-analysis","volume":"27","author":"Rojas","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib16","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.jhep.2023.08.025","article-title":"Collaborators. Changing from NAFLD through MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort","volume":"80","author":"Perazzo","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1017\/S0007114523000028","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with lifestyle habits in adults in Chile: a cross-sectional study from the National Health Survey 2016-2017","volume":"130","author":"Pettinelli","year":"2023","journal-title":"Br J Nutr"},{"key":"10.1016\/j.cld.2026.01.014_bib18","first-page":"35","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)","volume":"3","author":"Wong","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.cld.2026.01.014_bib19","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70017","article-title":"MetALD: new perspectives on an old overlooked disease","volume":"45","author":"Ayares","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/apt.17615","article-title":"Epidemiology and risk factors for histopathologic characteristics of non-alcoholic fatty liver disease in South America","volume":"58","author":"Akambase","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2026.01.014_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.cld.2026.01.014_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034934","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies","volume":"103","author":"van Son","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.cld.2026.01.014_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.cld.2026.01.014_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","article-title":"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Qi","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.014_bib27","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cld.2026.01.014_bib28","unstructured":"Organization. PAH. Nine Latin American and Caribbean countries intensify efforts to curb obesity with PAHO support. In; 2025."},{"key":"10.1016\/j.cld.2026.01.014_bib29","doi-asserted-by":"crossref","unstructured":"Motta M, Ribeiro H: Obesity and 2030 Agenda in Latin America: Prevention and Control Policies in Brazil and Chile. In: Walter Leal Filho (Editor-in-Chief) NA-R, Bruno Borsari, Paulo R. B. de Brito, Baltazar Andrade Guerra, ed. SDGs in the Americas and Caribbean Region: Springer International Publishing, 2022; 545-570.","DOI":"10.1007\/978-3-031-16017-2_34"},{"key":"10.1016\/j.cld.2026.01.014_bib30","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1017\/S1368980021001403","article-title":"Obesity in Latin America, a scoping review of public health prevention strategies and an overview of their impact on obesity prevention","volume":"24","author":"Palacios","year":"2021","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.cld.2026.01.014_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global Burden of Disease Study 2021","volume":"402","author":"Collaborators","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2026.01.014_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.puhe.2024.05.009","article-title":"The burden of type 2 diabetes mellitus in Latin America, 1990-2019: findings from the Global Burden of Disease study","volume":"233","author":"Ilic","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.cld.2026.01.014_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11892-020-01341-9","article-title":"Current State of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes across the continent","volume":"20","author":"Aviles-Santa","year":"2020","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.cld.2026.01.014_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s42255-024-00977-1","article-title":"Determinants of obesity in Latin America","volume":"6","author":"Ferreira","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.cld.2026.01.014_bib35","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.cgh.2024.05.052","article-title":"Genetics of metabolic dysfunction-associated steatotic liver disease: the state of the art update","volume":"22","author":"Sookoian","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70240","article-title":"Fifteen years of PNPLA3: transforming hepatology through human genetics","volume":"45","author":"Romeo","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2026.01.014_bib39","article-title":"Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.cld.2026.01.014_bib40","first-page":"857","article-title":"Decoding 17-Beta-hydroxysteroid dehydrogenase 13: a multifaceted perspective on its role in hepatic steatosis and associated disorders","volume":"12","author":"Demirtas","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/apt.70256","article-title":"Meta-analysis: effects of steatotic liver disease-associated genetic risk alleles on longitudinal outcomes","volume":"62","author":"Kubina","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2026.01.014_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cld.2026.01.014_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16123","article-title":"Global epidemiological impact of PNPLA3 I148M on liver disease","volume":"45","author":"Kozlitina","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib44","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1038\/s41467-025-58574-z","article-title":"Large-scale multi-omics analyses in hispanic\/latino populations identify genes for cardiometabolic traits","volume":"16","author":"Petty","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cld.2026.01.014_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12863-015-0255-3","article-title":"Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations","volume":"16","author":"Pontoriero","year":"2015","journal-title":"BMC Genet"},{"key":"10.1016\/j.cld.2026.01.014_bib46","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.cgh.2022.12.025","article-title":"Association of HSD17B13 and PNPLA3 with liver enzymes and fibrosis in hispanic\/latino individuals of diverse genetic ancestries","volume":"21","author":"Rutledge","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib47","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/liv.15364","article-title":"African genetic ancestry and protection against fatty liver disease","volume":"42","author":"Romeo","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100728","article-title":"African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population","volume":"27","author":"Cavalcante","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102495","article-title":"Global epidemiology and implications of PNPLA3 I148M variant in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"15","author":"Souza","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4254\/wjh.v12.i10.792","article-title":"PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease","volume":"12","author":"Lisboa","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5604\/01.3001.0010.8644","article-title":"More evidence for the genetic susceptibility of Mexican population to nonalcoholic fatty liver disease through PNPLA3","volume":"17","author":"Chinchilla-Lopez","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib52","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cld.2026.01.014_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2025.04.035","article-title":"High inherited risk predicts age-associated increases in fibrosis in patients with MASLD","volume":"83","author":"Diaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136406","article-title":"Polymorphism\u2019s MBOAT7 as risk and MTARC1 as protection for liver fibrosis in MASLD","volume":"26","author":"Rocha","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2026.01.014_bib55","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.15845","article-title":"Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus","volume":"44","author":"Lavrado","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib57","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.014_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101903","article-title":"Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group","volume":"30","author":"Diaz","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib59","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms","volume":"37","author":"Zelber-Sagi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2026.01.014_bib60","article-title":"Health literacy, social determinants of health, and disease prevention and control","volume":"6","author":"Coughlin","year":"2020","journal-title":"J Environ Health Sci"},{"key":"10.1016\/j.cld.2026.01.014_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.680452","article-title":"Introducing plant-based mediterranean diet as a lifestyle medicine approach in Latin America: opportunities within the Chilean context","volume":"8","author":"Figueroa","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.cld.2026.01.014_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100221","article-title":"Perspective: beyond the mediterranean diet-exploring Latin American, Asian, and African heritage diets as cultural models of healthy eating","volume":"15","author":"LeBlanc","year":"2024","journal-title":"Adv Nutr"},{"key":"10.1016\/j.cld.2026.01.014_bib63","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2026.01.014_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14656566.2025.2478917","article-title":"Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis","volume":"26","author":"Bhushan","year":"2025","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.cld.2026.01.014_bib65","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2026.01.014_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156397","article-title":"Semaglutide, the first approved GLP-1 receptor agonist for the management of metabolic dysfunction-associated steatohepatitis","volume":"174","author":"Boutari","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.cld.2026.01.014_bib67","article-title":"Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease","author":"Barritt","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.01.014_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas","volume":"7","author":"Diaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.014_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000649","article-title":"Multidisciplinary clinic model enhances liver and metabolic health outcomes in adults with MASH","volume":"9","author":"Stine","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2026.01.014_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13683","article-title":"Consensus on pharmacological treatment of obesity in Latin America","volume":"25","author":"Cappelletti","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.cld.2026.01.014_bib71","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"2025 concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the American college of Cardiology Solution Set Oversight Committee","volume":"86","author":"Gilbert","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cld.2026.01.014_bib72","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","article-title":"A global research priority agenda to advance public health responses to fatty liver disease","volume":"79","author":"Lazarus","year":"2023","journal-title":"J Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:59:01Z","timestamp":1778878741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1089326126000140"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.014","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}